A former competitive strategy director for Johnson & Johnson, who is accused of stealing confidential files as he transitioned to a position at Pfizer, has requested a New Jersey federal court to pause the civil suit against him. This request comes after the executive discovered he is under criminal investigation.
The case highlights the high stakes and intense scrutiny surrounding the movement of high-level employees between rival pharmaceutical giants. The intricacies of corporate espionage and the legal ramifications for breaches of confidentiality agreements are crucial considerations for large multinational corporations. For further details, the initial report on Law360 provides more information about the ongoing legal proceedings.